Nearly one-third of cancers detected in a high-risk screening program are already visible at the last negative MRI scan, and even more in women without BRCA mutations. This according to a study that evaluated the frequency of missed cancers on breast MRI in women participating in a high-risk screening program. For each cancer detected, researchers determined whether an MRI scan was available, which was reported to be negative. They found:
- Negative prior MRI scans were available for 131 breast cancers.
- 31% of cancers were visible at the initially negative MRI scan and 34% of cancers showed a minimal sign.
- The presence of a BRCA mutation strongly reduced the likelihood of visible findings in the last negative MRI.
Vreemann S, Gubern-Merida A, Lardenoije S, et al. The frequency of missed breast cancers in women participating in a high-risk MRI screening program. [Published online ahead of print January 31, 2018]. Breast Cancer Res Treat. doi:10.1007/s10549-018-4688-z.
This Week's Must Reads
Prophylactic Antibiotic Use in Labor & Delivery, Obstet Gynecol; 2018 Sep; Coleman, et al
USPSTF on Screening for Cervical Cancer, JAMA; 2018 Aug 21; US Preventive Services Task Force
Prevention of Obstetric Lacerations at Vaginal Delivery, Obstet Gynecol; 2018 Sep; Cichowski, et al
Effect of Menstrual Bleeding on IUD Discontinuation, Am J Obstet Gynecol; ePub 2018 Aug 28; Hobby, et al
Leukemia risk after maternal contraception use, Hargreave M et al. Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045(18)30479-0
Must Reads in Breast Cancer
Predicting Mammography Adherence by Income Level, Women’s Health Issues; ePub 2018 Aug 8; Gathirua-Mwangi, et al
Estrogen-alone Therapy & Invasive Breast Cancer, Menopause; ePub 2018 May 7; Shufelt, et al
Missed Breast Cancers in High Risk MRI Screening, Breast Cancer Res Treat; ePub 2018 Jan 31; Vreemann, et al
FDA Approves Biosimilar for Certain Breast Cancers, FDA news release; 2017 Dec 1
Black-White Disparities in Breast Cancer Survival, J Clin Oncol; ePub 2017 Oct 16; Jemal, et al